Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07106762
PHASE2/PHASE3

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

A Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer with Disease Progression on or After Immunotherapy

Official title: IZABRIGHT-Bladder01: A Randomized, Open-label, Phase 2/3 Trial of Izalontamab Brengitecan Versus Platinum-based Chemotherapy for Metastatic Urothelial Cancer in Participants With Disease Progression on or After an Immunotherapy-based Treatment

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

470

Start Date

2025-09-30

Completion Date

2033-11-18

Last Updated

2026-07-29

Healthy Volunteers

No

Interventions

DRUG

Iza-bren

Specified dose on specified days

DRUG

Cisplatin

Specified dose on specified days

DRUG

Gemcitabine

Specified dose on specified days

DRUG

Carboplatin

Specified dose on specified days

Locations (163)

Local Institution - 0167

Gilbert, Arizona, United States

Local Institution - 0162

Fullerton, California, United States

Palo Alto Center-Palo Alto Medical Foundation Research Institute

Palo Alto, California, United States

Sutter Health - Sutter Institute for Medical Research

Sacramento, California, United States

University of California Davis (UC Davis) Comprehensive Cancer Center

Sacramento, California, United States

Pacific Hematology Oncology Associates

San Francisco, California, United States

Sutter Santa Rosa

Santa Rosa, California, United States

Rocky Mountain Cancer Centers, LLP

Denver, Colorado, United States

Local Institution - 0245

Dillon, Colorado, United States

Shaw Cancer Center

Edwards, Colorado, United States

Sibley Memorial Hospital

Washington D.C., District of Columbia, United States

Miami Cancer Institute at Baptist Health, Inc.

Miami, Florida, United States

University of Kentucky Chandler Medical Center

Lexington, Kentucky, United States

Johns Hopkins Hospital

Baltimore, Maryland, United States

Local Institution - 0195

Boston, Massachusetts, United States

Karmanos Cancer Institute

Detroit, Michigan, United States

Local Institution - 0248

Buffalo, New York, United States

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Fairview Hospital

Cleveland, Ohio, United States

Cleveland Clinic

Cleveland, Ohio, United States

The James Outpatient Care West Campus

Columbus, Ohio, United States

Cleveland Clinic - Hillcrest Hospital

Mayfield Heights, Ohio, United States

Local Institution - 0141

Portland, Oregon, United States

SCRI Oncology Partners

Nashville, Tennessee, United States

Local Institution - 0084

Nashville, Tennessee, United States

Texas Oncology - West Texas

Abilene, Texas, United States

Local Institution - 0187

Austin, Texas, United States

Intermountain Medical Center

Murray, Utah, United States

St George Regional Hospital Cancer Center

St. George, Utah, United States

University of Virginia Health System

Charlottesville, Virginia, United States

Local Institution - 0188

Norfolk, Virginia, United States

Local Institution - 0200

Seattle, Washington, United States

Fred Hutchinson Cancer Center

Seattle, Washington, United States

University of Washington Medical Center - Montlake

Seattle, Washington, United States

Instituto Alexander Fleming

Caba, Buenos Aires, Argentina

Hospital Británico de Buenos Aires

CABA, Buenos Aires, Argentina

Asociación de Beneficencia Hospital Sirio Libanés

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Hospital Italiano de Buenos Aires

ABB, Buenos Aires F.D., Argentina

IONC Instituto Oncologico de Cordoba - Fundacion Richardet Longo

Córdoba, Argentina

Fundacion Centro Oncologico de Integración Regional

Mendoza, Argentina

Macquarie University

Macquarie University, New South Wales, Australia

GenesisCare North Shore

St Leonards, New South Wales, Australia

Austin Health

Heidelberg, Victoria, Australia

Medizinische Universität Wien

Vienna, State of Vienna, Austria

Klinik Ottakring

Vienna, State of Vienna, Austria

Medizinische Universitaet Innsbruck

Innsbruck, Tyrol, Austria

ZAS Augustinus

Wilrijk, Antwerpen, Belgium

AZ Maria Middelares

Ghent, Oost-Vlaanderen, Belgium

UZ Gent

Ghent, Oost-Vlaanderen, Belgium

Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman

Liège, Belgium

Local Institution - 0129

Salvador, Estado de Bahia, Brazil

Local Institution - 0121

Porto Alegre, Rio Grande do Sul, Brazil

Local Institution - 0130

Rio de Janeiro, Brazil

Local Institution - 0124

São Paulo, Brazil

Local Institution - 0020

Edmonton, Alberta, Canada

The Ottawa Hospital Cancer Centre

Ottawa, Ontario, Canada

Princess Margaret Cancer Centre

Toronto, Ontario, Canada

McGill University Health Centre

Montreal, Quebec, Canada

Local Institution - 0050

Beijing, Beijing Municipality, China

Local Institution - 0224

Beijing, Beijing Municipality, China

Local Institution - 0048

Fuzhou, Fujian, China

The First Affiliated Hospital Of Fujian Medical University

Fuzhou, Fujian, China

Local Institution - 0056

Xiamen, Fujian, China

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China

Zhujiang Hospital

Guangzhou, Guangdong, China

Local Institution - 0064

Zhengzhou, Henan, China

Local Institution - 0059

Changsha, Hunan, China

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School

Nanjing, Jiangsu, China

Local Institution - 0046

Nanjing, Jiangsu, China

Local Institution - 0114

Nantong, Jiangsu, China

The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, China

Shandong Cancer Hospital

Jinan, Shandong, China

The Affiliated Hospital of Qingdao University

Qingdao, Shandong, China

Yantai Yuhuangding Hospital

Yantai, Shandong, China

Local Institution - 0042

Shanghai, Shanghai Municipality, China

Sichuan Cancer hospital

Chengdu, Sichuan, China

West China Hospital, Sichuan University

Chengdu, Sichuan, China

Tianjin Medical University Cancer Institute & Hospital

Tianjin, Tianjin Municipality, China

Local Institution - 0227

Tianjin, Tianjin Municipality, China

Local Institution - 0157

Hangzhou, Zhejiang, China

The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology

Wuhan, China

Local Institution - 0115

Brno, Brno-město, Czechia

Local Institution - 0146

Hradec Králové, Hradec Králové, Czechia

Local Institution - 0041

Prague, Praha 5, Czechia

Centre Antoine-Lacassagne

Nice, Alpes-Maritimes, France

CHU Strasbourg-Hautepierre

Strasbourg, Alsace, France

CHU de Bordeaux Hop St ANDRE

Bordeaux, Aquitaine, France

Centre Leon Berard

Lyon Cedex08, Auvergne-Rhône-Alpes, France

CHRU de Brest

Brest, Finistère, France

Hôpital Foch

Suresnes, Hauts-de-Seine, France

Institut de Cancérologie de l'Ouest

Saint-Herblain, Loire-Atlantique, France

Local Institution - 0005

Marseille, Provence-Alpes-Côte d'Azur Region, France

Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne

Clermont-Ferrand, Puy-de-Dôme, France

Gustave Roussy

Villejuif, Val-de-Marne, France

Hôpital Européen Georges Pompidou

Paris, France

Groupe hospitalier Paris saint Joseph

Paris, Île-de-France Region, France

NCT

Heidelberg, Baden-Wurttemberg, Germany

And 63 more locations on ClinicalTrials.gov